BCL2L11 and neoplasm: An alternative approach is to up-regulate pro-apoptotic proteins (e.g., Bim) that prime tumor cells (e.g., by pre-occupying or saturating anti-apoptotic proteins) for death induced by Bcl-2 inhibitors (93).